Alerts will be sent to your verified email
Verify Email
SHIVALIK
|
Shivalik Rasayan
|
Wanbury
|
Anuh Pharma
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Chemical Sector
|
|||
|
Capacity Utilization - Dimethoate
|
95.0 % | n/a | n/a |
|
Realization/Tonne - Dimethoate
|
299080.92 Rs/MT | n/a | n/a |
|
Realization/Tonne - Sodium hydrosulfide
|
4487.46 Rs/MT | n/a | n/a |
|
Financials
|
|||
|
5 yr Average ROE
|
7.33 % | -30.56 % | 14.73 % |
|
5yr average Equity Multiplier
|
1.84 | -3.1 | 1.72 |
|
5yr Average Asset Turnover Ratio
|
0.47 | 1.51 | 1.28 |
|
5yr Avg Net Profit Margin
|
8.37 % | 7.58 % | 6.73 % |
|
Price to Book
|
1.91 | 23.36 | 3.01 |
|
P/E
|
59.54 | 20.62 | 18.16 |
|
5yr Avg Cash Conversion Cycle
|
79.22 Days | -119.82 Days | 32.26 Days |
|
Inventory Days
|
63.09 Days | 20.62 Days | 54.64 Days |
|
Days Receivable
|
114.67 Days | 49.78 Days | 101.36 Days |
|
Days Payable
|
157.87 Days | 205.91 Days | 121.84 Days |
|
5yr Average Interest Coverage Ratio
|
10.93 | 2.36 | 41.88 |
|
5yr Avg ROCE
|
9.58 % | -51.74 % | 19.85 % |
|
5yr Avg Operating Profit Margin
|
18.09 % | 4.22 % | 9.86 % |
|
5 yr average Debt to Equity
|
0.16 | -0.61 | 0.07 |
|
5yr CAGR Net Profit
|
-1.91 % | -2.79 % | 33.23 % |
|
5yr Average Return on Assets
|
3.97 % | 11.1 % | 8.83 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
47.37 % | 39.76 % | 69.92 % |
|
Share Pledged by Promoters
|
0.0 | 76.74 % | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-2.95 % | -0.13 % | -0.52 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Shivalik Rasayan
|
Wanbury
|
Anuh Pharma
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Operating Profit Break-Up
|
Operating Profit Break-Up
|
-
|
-
|
|
Asset Break-Up
|
Asset Break-Up
|
-
|
-
|